Vaccine Development and Collaborations: Lessons from the History of the Meningococcal A Vaccine (1969-73)

被引:4
|
作者
Baylac-Paouly, Baptiste [1 ,2 ]
机构
[1] Univ Claude Bernard Lyon 1, Univ Lyon, S2HEP, EA 4148, Villeurbanne, France
[2] S2HEP, BailmentLa Pagode 38 Blvd Niels Bohr,Campus DOUA, F-69622 Villeurbanne, France
关键词
Cerebrospinal meningitis A; Institut Merieux; World Health Organization; Collaborations; Meningococcal vaccine; Africa; SEROGROUP;
D O I
10.1017/mdh.2019.43
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Based on a wide range of historical sources, including published scientific literature and archives (Institut Merieux, WHO and IMTSSA), this article examines the history of the development of the meningococcal A vaccine between 1969 and 1973. It explores the social factors of vaccine development including various collaborations, informal discussions, the circulation of products and materials, formal meetings, trials and setbacks to highlight the complex reality of the development, production and use of the vaccine. Inscribed in a 'Golden Age' of vaccine development and production, this episode not only adds to the scholarship on the history of vaccines, which has tended to focus on a narrative of progress, but also considers the sharing of knowledge through collaborations, and the risks involved in the development of a vaccine. Finally, this perspective reveals the uncertainties and difficulties underlying the production of an effective vaccine.
引用
收藏
页码:435 / 453
页数:19
相关论文
共 50 条
  • [31] A history of hookworm vaccine development
    Schneider, Brent
    Jariwala, Amar R.
    Periago, Maria Victoria
    Gazzinelli, Maria Flavia
    Bose, Swaroop N.
    Hotez, Peter J.
    Diemert, David J.
    Bethony, Jeffrey M.
    HUMAN VACCINES, 2011, 7 (11): : 1234 - 1244
  • [32] Industrial development and innovation: Some lessons from vaccine procurement
    Srinivas, Smita
    WORLD DEVELOPMENT, 2006, 34 (10) : 1742 - 1764
  • [33] HIV vaccine development: Lessons from the past and promise for the future
    Spearman, P
    CURRENT HIV RESEARCH, 2003, 1 (01) : 101 - 120
  • [34] HIV vaccine development: Lessons from the past, informing the future
    Bradac, James
    Dieffenbach, Carl W.
    IDRUGS, 2009, 12 (07) : 435 - 439
  • [35] Vaccine Development Throughout History
    Saleh, Amr
    Qamar, Shahraz
    Tekin, Aysun
    Singh, Romil
    Kashyap, Rahul
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [36] Safety Data on Meningococcal Polysaccharide Vaccine from the Vaccine Adverse Event Reporting System
    Ball, R
    Braun, MM
    Mootrey, GT
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) : 1273 - 1280
  • [37] Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons
    Enwere, Godwin C.
    Paranjape, Gandhali
    Kulkarni, Prasad S.
    Ginde, Manisha
    Hartmann, Katharina
    Viviani, Simonetta
    Chaumont, Julie
    Martellet, Lionel
    Makadi, Marie-Francoise
    Ivinson, Karen
    Marchetti, Elisa
    Herve, Jacques
    Kertson, Kim
    LaForce, F. Marc
    Preziosi, Marie-Pierre
    CLINICAL INFECTIOUS DISEASES, 2015, 61 : S501 - S506
  • [38] A novel interaction between factor HSCR 6 and the meningococcal vaccine candidate GNA1870: Implications for meningococcal pathogenesis and vaccine development
    Ngampasutadol, Jutamas
    Welsch, Jo Anne
    Lewis, Lisa A.
    Jarva, Hanna
    Madico, Guillermo
    Vogel, Ulrich
    Visintin, Alberto
    Ram, Sanjay
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 220 - 220
  • [39] The Impact of Nucleotide Sequence Analysis on Meningococcal Vaccine Development and Assessment
    Maiden, Martin Christopher James
    FRONTIERS IN IMMUNOLOGY, 2019, 9
  • [40] Lessons from the Bolivian vaccine mandate
    Rivas, Diana Reyna Zeballos
    Ticona, Juan P. Aguilar
    Doss-Gollin, Simon
    VACCINE, 2023, 41 (27) : 3951 - 3953